These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1978509)

  • 41. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.
    Ditter SM; Mirra SS
    Neurology; 1987 May; 37(5):754-60. PubMed ID: 3033544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neural transplants: prospects for Alzheimer's disease.
    Gage FH; Chen KS
    Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):94-9. PubMed ID: 1352469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First signs of glaucoma injury occur in the brain. What has generally been considered an eye disease is actually related to conditions such as Alzheimer's and Parkinson's diseases.
    Duke Med Health News; 2010 May; 16(5):4-5. PubMed ID: 20518132
    [No Abstract]   [Full Text] [Related]  

  • 44. Quantitative changes in some subcortical nuclei in aging, Alzheimer's disease and Parkinson's disease.
    Jellinger K
    Neurobiol Aging; 1987; 8(6):556-61. PubMed ID: 3323929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lewy bodies of Parkinson's disease contain neurofilament antigens.
    Goldman JE; Yen SH; Chiu FC; Peress NS
    Science; 1983 Sep; 221(4615):1082-4. PubMed ID: 6308771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of two antigens in parkinsonian Lewy bodies.
    Hirsch E; Ruberg M; Portier MM; Dardenne M; Agid Y
    Brain Res; 1988 Feb; 441(1-2):139-44. PubMed ID: 3359227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lewy bodies in the enteric nervous system in Parkinson's disease.
    Wakabayashi K; Takahashi H; Takeda S; Ohama E; Ikuta F
    Arch Histol Cytol; 1989; 52 Suppl():191-4. PubMed ID: 2554944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dementia and Parkinson's disease--pathological and neurochemical considerations.
    Quinn NP; Rossor MN; Marsden CD
    Br Med Bull; 1986 Jan; 42(1):86-90. PubMed ID: 3006860
    [No Abstract]   [Full Text] [Related]  

  • 49. Probing modifications of the neuronal cytoskeleton.
    Doering LC
    Mol Neurobiol; 1993; 7(3-4):265-91. PubMed ID: 8179841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dementia of Alzheimer type (DAT)--a review of its morbid anatomy.
    Ulrich J; Probst A; Anderton BH; Kahn J
    Klin Wochenschr; 1986 Feb; 64(3):103-14. PubMed ID: 3005758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen.
    Braak H; Rüb U; Gai WP; Del Tredici K
    J Neural Transm (Vienna); 2003 May; 110(5):517-36. PubMed ID: 12721813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Neuropathology of Alzheimer's disease: recent experimental aspects].
    Hof PR
    Schweiz Arch Neurol Psychiatr (1985); 1993; 144(5):426-40. PubMed ID: 7504834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Is leuko-araiosis in Alzheimer's disease, in Parkinson's disease and in healthy elderly persons the result of Wallerian degeneration?].
    Leys D; Pruvo JP; Soetaert G; Vermersch P; Rapoport A; Clarisse J; Petit H
    Acta Neurol Belg; 1989; 89(3-4):249-52. PubMed ID: 2516973
    [No Abstract]   [Full Text] [Related]  

  • 54. The hypothalamic lateral tuberal nucleus: normal anatomy and changes in neurological diseases.
    Kremer HP
    Prog Brain Res; 1992; 93():249-61. PubMed ID: 1362279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of astrocytes in brain function and disease.
    Sidoryk-Wegrzynowicz M; Wegrzynowicz M; Lee E; Bowman AB; Aschner M
    Toxicol Pathol; 2011 Jan; 39(1):115-23. PubMed ID: 21075920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imaging non-dopaminergic function in Parkinson's disease.
    Brooks DJ
    Mol Imaging Biol; 2007; 9(4):217-22. PubMed ID: 17340229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine acetylcholine imbalance in Parkinson's disease. Possible regenerative overgrowth of cholinergic axon terminals.
    Spehlmann R; Stahl SM
    Lancet; 1976 Apr; 1(7962):724-6. PubMed ID: 56538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lewy bodies.
    Forno LS
    N Engl J Med; 1986 Jan; 314(2):122. PubMed ID: 3941689
    [No Abstract]   [Full Text] [Related]  

  • 59. [Changes in brain level of neurotransmitters].
    Kanazawa I
    Nihon Naika Gakkai Zasshi; 1991 Jul; 80(7):1148-52. PubMed ID: 1680945
    [No Abstract]   [Full Text] [Related]  

  • 60. Light and electron microscopic identification of monoaminergic terminals in the central nervous system.
    Záborszky L; Léránth C; Palkovits M
    Brain Res Bull; 1979; 4(1):99-117. PubMed ID: 37996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.